Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India · Delayed Price · Currency is INR 816.80
-12.45 (-1.50%)
Aug 21, 2026, 3:30 PM IST
Aarti Pharmalabs Market Cap
Aarti Pharmalabs has a market cap or net worth of 74.05 billion as of August 21, 2026. Its market cap has decreased by -2.83% in one year.
Market Cap
74.05B
Enterprise Value
81.89B
Revenue
19.69B
Ranking
n/a
PE Ratio
36.21
Stock Price
816.80
ChartMarket Cap Chart
Since January 30, 2023, Aarti Pharmalabs's market cap has increased from 26.12B to 74.05B, an increase of 183.46%. That is a compound annual growth rate of 34.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 74.05B | 8.57% |
| Dec 31, 2025 | 68.20B | 9.67% |
| Dec 31, 2024 | 62.19B | 36.04% |
| Dec 29, 2023 | 45.72B | 75.00% |
| Jan 30, 2023 | 26.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 170.95B |
| Alivus Life Sciences | 168.15B |
| Alembic Pharmaceuticals | 160.69B |
| NATCO Pharma | 158.84B |
| Sudeep Pharma | 130.61B |
| Akums Drugs and Pharmaceuticals | 115.33B |
| Strides Pharma Science | 88.26B |
| Sun Pharma Advanced Research Company | 62.67B |